Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.
Angiotensin-converting enzyme (ACE) inhibitor availability is changing. This piece of microlearning outlines the changes and gives links to useful resources.
Episode five of our Legendary Conversations podcast focuses on the appropriate use of antibiotics for uncomplicated urinary tract infection. Lauren Smith, senior practice fellow at the University of Otago School of Pharmacy, uses a case study to discuss the current recommendations for UTI treatment.
This piece of microlearning explores the importance of antimicrobial stewardship in Aotearoa New Zealand.
This video is a recording of the live webinar hosted by He Ako Hiringa on 22 November 2022. Dr Sharon Gardiner and associate professor Matire Harwood highlight the importance of antimicrobial stewardship in New Zealand.
This editable PDF helps you to delve into the EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions.
*New audit section*
An additional audit/CQI section allows you or your practice team to repeat the process, completing activities that may be used for Foundation Standard or the Cornerstone CQI or Equity modules.
Antimicrobial resistance presents an imminent threat to the future of New Zealanders’ wellbeing and access to effective, safe healthcare. This article describes initiatives for improving antimicrobial stewardship, the New Zealand antimicrobial prescribing landscape as it stands, and actions that can be taken immediately in primary care.
The ACE inhibitor cilazapril will soon be delisted – new alternatives include ramipril capsules and an 8mg perindopril tablet.
This article summarises recent and upcoming changes to ACE inhibitor availability, and provides a dose equivalence table and advice for switching between medicines.
Intended for all members of the healthcare team, this video explores improving asthma outcomes and achieving health equity by making effective connections with patients and whānau.
World Antimicrobial Awareness Week is running from 18-24 November 2022. Aligning with the global action plan endorsed by WHO, the prime minister’s chief science advisor recommends collective and urgent action to mitigate the risk of antimicrobial resistance. Read this aHAH! moment to find out more.
The funded brand of paracetamol oral liquid, Paracare and Paracare Double Strength, will soon be replaced with different brands. The strawberry and orange flavours will remain, but the liquids will be colour free and supplied in 200ml bottles. Learn more about the changes here.
Available evidence indicates that Evusheld is useful against only a small number of the variants of COVID-19 in New Zealand. It is not routinely recommended for use. Pharmac continues to review this regularly.
The funded brand of morphine ampoules has changed, as a result of Pharmac’s annual tender process. Learn more about the changes here.